High conflict zones linked to severe hyperglycemia and PTSD in diabetics

The link between psychological trauma and metabolic disease has gained striking new evidence from one of the most volatile corners of the Middle East. A new cross-sectional study conducted among diabetic patients living in and around Ein el Helwe, Lebanon’s largest Palestinian refugee camp and the site of repeated armed clashes, reports that nearly three-quarters of participants screened positive for post-traumatic stress disorder, and that roughly one in seven reported dangerously elevated blood sugar levels. The research, led by a team from Beirut Arab University and published in BMC Psychiatry, offers a rare quantitative window into how living under the constant threat of battlefield-style violence shapes both mind and body in people already managing a chronic endocrine condition.

The study set out with two intertwined goals: to determine whether the recurrent conflicts at Ein el Helwe were associated with marked hyperglycemia among diabetic residents, and to establish the prevalence of post-traumatic stress disorder within the same population. Ein el Helwe has periodically erupted into armed confrontations that researchers describe as battlefield-like, with exchanges of heavy gunfire, shelling and prolonged sieges that trap civilians inside crowded urban streets. For people with diabetes, such events are not merely frightening; they can directly destabilize the delicate hormonal balance that governs blood glucose. Chronic activation of the stress axis drives sustained secretion of cortisol and catecholamines, hormones that raise blood glucose by stimulating glucose production in the liver and promoting insulin resistance in muscle and fat tissue. In theory, a population living under persistent threat should show both elevated rates of trauma-related psychiatric illness and worse glycemic control, and this study was designed to test that expectation empirically.

The researchers adopted a cross-sectional design, surveying 220 participants with diabetes who lived in the affected area. The sample was predominantly female, with a mean age of 53.22 years and a standard deviation of 13.98, indicating a middle-aged cohort with wide age representation from young adults to the elderly. To assess psychological trauma, the team used an Arabic version of a validated post-traumatic stress disorder scale, allowing respondents to report symptoms in their native language. Glycemic status was captured through patient self-report: each participant provided the most recent reading of their fasting blood sugar level, and values reaching the threshold defined by the researchers as marked hyperglycemia were recorded as such. While self-reported glucose values are inherently less precise than laboratory-measured hemoglobin A1C, the approach reflects the practical realities of research in active conflict settings, where clinical infrastructure is disrupted and follow-up laboratory testing is often impossible.

The psychological findings were stark. Post-traumatic stress disorder was identified in 71.8 percent of participants, with a mean score on the PTSD scale of 45.84 and a standard deviation of 9.94. In other words, more than seven in ten diabetic patients surveyed carried a symptom burden consistent with post-traumatic stress disorder, a rate that towers over prevalence estimates in general populations, which typically range from a few percent to around ten percent depending on the country and measurement instrument. The elevated mean score suggests that symptoms were not marginal; respondents reported substantial clusters of re-experiencing, avoidance and hyperarousal symptoms of the kind catalogued in the Diagnostic and Statistical Manual of Mental Disorders. Living through gunfire, witnessing injury and death, enduring displacement and facing the constant anticipation of the next clash appear to have etched deep psychological scars into this community.

Marked hyperglycemia was reported by almost 15 percent of participants, a figure the authors interpret as a signal of compromised metabolic control within the population. That proportion may seem modest next to the PTSD rate, but it must be read against a backdrop of limited access to medication, erratic food supplies, interrupted medical care and the physiological toll of chronic stress. When the researchers moved from raw prevalence to multivariate statistical analysis, a clearer picture of who was most vulnerable emerged. Three factors independently shaped glycemic control: educational level, the specific living area within or around the camp, and the severity of avoidance and numbness symptoms, one of the core symptom clusters of post-traumatic stress disorder. The prominence of avoidance and numbness is particularly telling, because these symptoms reflect emotional shutdown and social withdrawal, states that can undermine the daily self-management behaviors diabetes demands, from monitoring glucose to adhering to medication schedules and maintaining dietary discipline.

The socioeconomic dimensions of the findings deserve close attention. Education level and living area are both markers of material circumstance, and their independent association with blood sugar control underscores that metabolic health in conflict zones cannot be disentangled from poverty, housing quality and access to health services. The authors also point to sociodemographic factors, lifestyle patterns and cultural aspects as contributors to their results, acknowledging that the relationship between trauma and hyperglycemia is mediated by a web of behavioral and contextual variables. In a refugee setting such as Ein el Helwe, where residents of Palestinian origin have faced decades of displacement and precarity, the accumulation of adversity across a lifetime may compound the acute stresses of recent clashes, creating a cumulative allostatic load that manifests in both psychiatric and endocrine pathology.

The biological plausibility of a direct trauma-hyperglycemia pathway is well established in the broader literature. Post-traumatic stress disorder has been repeatedly linked to dysregulation of the hypothalamic-pituitary-adrenal axis, altered sympathetic nervous system activity, systemic inflammation and insulin resistance, mechanisms that collectively increase the risk of type 2 diabetes and worsen control in those who already have it. Conversely, the burden of managing a chronic disease like diabetes can itself be traumatic, raising the possibility of bidirectional reinforcement in which poor glycemic control heightens psychological distress, and distress in turn destabilizes glucose metabolism. Sedentary behavior imposed by curfews and gunfire, stress-related overeating or reliance on cheap, high-calorie foods during shortages, sleep disruption caused by nighttime violence, and smoking or other coping behaviors may all serve as intermediate links between the sound of artillery and the number on a glucose meter.

The study’s limitations are candidly acknowledged by its authors, and they matter for interpretation. The cross-sectional design captures a single snapshot in time and cannot establish whether trauma preceded hyperglycemia or vice versa. Glycemia was assessed by patient report of the most recent fasting blood sugar reading rather than by standardized laboratory measurement of fasting glucose or hemoglobin A1C, introducing potential recall and measurement error. The reliance on a single camp population, while offering unusual homogeneity of exposure, limits generalizability to other conflict settings. The authors explicitly call for future studies to monitor glycemia levels directly and longitudinally to produce more reliable findings, and they suggest that objective biochemical measures would strengthen the evidentiary base considerably.

Even with these caveats, the work carries weighty implications for clinical practice and humanitarian policy. Health programs serving populations in conflict zones routinely treat physical and mental illness in parallel silos, with diabetes clinics operating separately from mental health services, if mental health services exist at all. The finding that avoidance and numbness symptoms independently predict poorer glycemic control argues for integrated care models in which screening for post-traumatic stress disorder becomes a routine part of diabetes management, and in which psychological interventions are recognized as tools of metabolic medicine. Trauma-informed approaches to chronic disease care, including attention to safety, trust and emotional regulation, may be essential for achieving glycemic targets among patients whose daily lives are shaped by violence. Conversely, stabilizing blood sugar may buffer some of the physiological consequences of trauma, suggesting that metabolic care is also a form of mental health protection.

The researchers, based in the Nursing Department of the Faculty of Health Sciences at Beirut Arab University, secured ethical approval from their institution’s Institutional Review Board and obtained informed consent from all participants in simple Arabic, including residents of Palestinian origin categorized as refugees, who were assured that participation carried no privileges and non-participation no penalties. The study received no external funding, and the authors declare no competing interests. Published as an open-access article with a citable DOI, the research arrives at a moment when armed conflict continues to flare across the region, and when the global health community is increasingly recognizing that wars injure people in ways that outlast the bullets. For the diabetic patients of Ein el Helwe, the findings confirm what their daily experience suggests: the violence outside their doors does not stay outside their bodies. It registers in their minds as post-traumatic stress, and in their bloodstreams as sugar their bodies can no longer regulate. Addressing that dual burden will require health systems that treat the psyche and the pancreas as parts of a single, war-scarred whole.